Detalles de la búsqueda
1.
Meta-analysis of stomatitis in clinical studies of everolimus: incidence and relationship with efficacy.
Ann Oncol
; 27(3): 519-25, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26759276
2.
RECORD-2: phase II randomized study of everolimus and bevacizumab versus interferon α-2a and bevacizumab as first-line therapy in patients with metastatic renal cell carcinoma.
Ann Oncol
; 26(7): 1378-84, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25851632
3.
Everolimus in metastatic renal cell carcinoma patients intolerant to previous VEGFr-TKI therapy: a RECORD-1 subgroup analysis.
Br J Cancer
; 106(9): 1475-80, 2012 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-22441644
4.
Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors.
Ann Oncol
; 23(9): 2399-2408, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22357447
5.
Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986.
J Clin Oncol
; 23(22): 4856-65, 2005 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15939923
6.
A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial.
Eur J Cancer
; 41(3): 398-403, 2005 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-15691639
7.
The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921).
Leukemia
; 17(5): 859-68, 2003 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-12750698
8.
The EORTC Gastrointestinal Tract Cancer Group: 40 years of research contributing to improved GI cancer management.
Eur J Cancer
; 38 Suppl 4: S65-70, 2002 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-11858968
9.
Highlights and strategies of the EORTC Leukemia Group. European Organisation for Research and Treatment of Cancer.
Eur J Cancer
; 38 Suppl 4: S94-9, 2002 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-11858973
10.
The European Organization for Research and Treatment of Cancer Gastrointestinal Group Trials: surgery and liver surgery in Europe.
Surg Oncol Clin N Am
; 10(4): 795-806, ix, 2001 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-11641091
11.
Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study.
Eur J Cancer
; 48(3): 333-9, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22209391
12.
FAD-glycerophosphate dehydrogenase activity in pancreatic islets and liver of ob/ob mice.
Biochem Mol Biol Int
; 30(3): 397-402, 1993 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-8401296
13.
FAD-linked glycerophosphate dehydrogenase activity in islets, liver, and splenocytes of NOD mice.
Biochem Med Metab Biol
; 50(1): 67-74, 1993 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-8373636
Resultados
1 -
13
de 13
1
Próxima >
>>